Drugs and hepatotoxicity: a comprehensive review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261373Keywords:
Drugs and hepatotoxicity, Xenobiotic metabolism, AdvancesAbstract
Hepatotoxicity is a leading cause of acute and chronic liver disease worldwide. It denotes liver damage resulting from exposure to pharmaceuticals, chemicals, herbal preparations, or other foreign compounds. It is a major concern in clinical practice and drug development, as liver injury is a frequent cause of treatment discontinuation and drug withdrawal. Owing to its central role in metabolism and detoxification, the liver is particularly susceptible to toxic injury. The spectrum of hepatotoxicity ranges from mild, transient elevations in liver enzymes to severe acute liver failure. This review discusses the role of the liver in xenobiotic metabolism, mechanisms of hepatotoxicity, types of liver injury, implicated drugs, diagnostic approaches, management strategies, and preventive measures. Emphasis is placed on integrating mechanistic insights with clinical applications to aid in early detection, better therapeutic strategies, and reduction of morbidity and mortality associated with hepatotoxicity.
Metrics
References
Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015;25(8):416-26. DOI: https://doi.org/10.1097/FPC.0000000000000150
McGill MR, Jaeschke H. Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis. Pharm Res. 2013;30(9):2174-87. DOI: https://doi.org/10.1007/s11095-013-1007-6
Kadam R, Palkar M, Pingili RB. Mechanisms involved in the valproic acid-induced hepatotoxicity: a comprehensive review. Toxicol Mech Methods. 2025;35(6):565-80. DOI: https://doi.org/10.1080/15376516.2025.2459176
Tong V, Teng XW, Chang TKH, Abbott FS. Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat Hepatocytes. Toxicol Sci. 2005;86(2):436-43. DOI: https://doi.org/10.1093/toxsci/kfi185
Liao J, Lu Q, Li Z, Li J, Zhao Q, Li J. Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products. Front Pharmacol. 2023;14:1122632. DOI: https://doi.org/10.3389/fphar.2023.1122632
Chidiac AS, Buckley NA, NF Cairns R. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opin Drug Metab Toxicol. 2023;19(5):297-317. DOI: https://doi.org/10.1080/17425255.2023.2223959
Andrade V, Guerra M, Jardim C, Melo F, Silva W, Ortega JM, et al. Nucleoplasmic calcium regulates cell proliferation through legumain. J Hepatol. 2011;55(3):626-35. DOI: https://doi.org/10.1016/j.jhep.2010.12.022
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399-408. DOI: https://doi.org/10.1002/hep.27317
Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019;381(3):264-73. DOI: https://doi.org/10.1056/NEJMra1816149
Reuben A, Koch DG, Lee WM. Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study. Hepatology. 2010;52(6):2065-76. DOI: https://doi.org/10.1002/hep.23937
Jaeschke H. Mechanisms of Hepatotoxicity. Toxicol Sci. 2002;65(2):166-76. DOI: https://doi.org/10.1093/toxsci/65.2.166
Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4(6):489-99. DOI: https://doi.org/10.1038/nrd1750
Fontana RJ. Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives. Gastroenterology. 2014;146(4):914-28. DOI: https://doi.org/10.1053/j.gastro.2013.12.032
Watkins P. Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury. Semin Liver Dis. 2009;29(04):393-9. DOI: https://doi.org/10.1055/s-0029-1240008
Heard KJ. Acetylcysteine for Acetaminophen Poisoning. N Engl J Med. 2008;359(3):285-92. DOI: https://doi.org/10.1056/NEJMct0708278
Avella DM, Li G, Schell TD, Liu D, Zhang SS, Lou X, et al. Regression of Established Hepatocellular Carcinoma Is Induced by Chemoimmunotherapy in An Orthotopic Murine Model. Hepatology. 2012;55(1):141-52. DOI: https://doi.org/10.1002/hep.24652
Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323-30. DOI: https://doi.org/10.1016/0895-4356(93)90101-6
Sun C, Yang X, Tang L, Chen J. A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system. Expert Opin Drug Saf. 2024;23(8):1049-60. DOI: https://doi.org/10.1080/14740338.2023.2277801
Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol. 2014;109(7):950-66. DOI: https://doi.org/10.1038/ajg.2014.131
Bernal W, Wendon J. Acute Liver Failure. N Engl J Med. 2013;369(26):2525-34. DOI: https://doi.org/10.1056/NEJMra1208937
Niu H, Alvarez-Alvarez I, CM. Artificial Intelligence: An Emerging Tool for Studying Drug-Induced Liver Injury. Liver Int. 2025;45(3):e70038. DOI: https://doi.org/10.1111/liv.70038
Mostafa F, Chen M. Computational models for predicting liver toxicity in the deep learning era. Front Toxicol. 2024;5:1340860. DOI: https://doi.org/10.3389/ftox.2023.1340860
Downloads
Published
How to Cite
Issue
Section
